Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Brentuximab vedotin in multifocal cutaneous anaplastic large cell lymphoma in a patient with human immunodeficiency virus following Hodgkin lymphoma.

Wolf S, Goiriz R, Dhairyawan R, Paige D, Rizvi H, Haroon A, Montoto S.

Clin Exp Dermatol. 2018 Nov 14. doi: 10.1111/ced.13824. [Epub ahead of print] No abstract available.

PMID:
30430604
2.

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection.

Tio M, Rai R, Ezeoke OM, McQuade JL, Zimmer L, Khoo C, Park JJ, Spain L, Turajlic S, Ardolino L, Yip D, Goldinger SM, Cohen JV, Millward M, Atkinson V, Kane AY, Ascierto PA, Garbe C, Gutzmer R, Johnson DB, Rizvi HA, Joshua AM, Hellmann MD, Long GV, Menzies AM.

Eur J Cancer. 2018 Nov;104:137-144. doi: 10.1016/j.ejca.2018.09.017. Epub 2018 Oct 20.

PMID:
30347289
3.

The Role of Human Papillomaviruses and Polyomaviruses in BRAF-Inhibitor Induced Cutaneous Squamous Cell Carcinoma and Benign Squamoproliferative Lesions.

Purdie KJ, Proby CM, Rizvi H, Griffin H, Doorbar J, Sommerlad M, Feltkamp MC, der Meijden EV, Inman GJ, South AP, Leigh IM, Harwood CA.

Front Microbiol. 2018 Aug 14;9:1806. doi: 10.3389/fmicb.2018.01806. eCollection 2018.

4.

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, Martínez-Bernal G, Ferrara R, Lai WV, Hendriks LEL, Sabari JK, Caramella C, Plodkowski AJ, Halpenny D, Chaft JE, Planchard D, Riely GJ, Besse B, Hellmann MD.

J Clin Oncol. 2018 Oct 1;36(28):2872-2878. doi: 10.1200/JCO.2018.79.0006. Epub 2018 Aug 20.

PMID:
30125216
5.

Maternal protein restriction induces gastrointestinal dysfunction and enteric nervous system remodeling in rat offspring.

Aubert P, Oleynikova E, Rizvi H, Ndjim M, Le Berre-Scoul C, Grohard PA, Chevalier J, Segain JP, Le Drean G, Neunlist M, Boudin H.

FASEB J. 2018 Aug 1:fj201800079R. doi: 10.1096/fj.201800079R. [Epub ahead of print]

PMID:
30067379
6.

Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers.

Offin M, Rizvi H, Tenet M, Ni A, Sanchez-Vega F, Li BT, Drilon A, Kris MG, Rudin CM, Schultz N, Arcila ME, Ladanyi M, Riely GJ, Yu H, Hellmann MD.

Clin Cancer Res. 2018 Jul 25. doi: 10.1158/1078-0432.CCR-18-1102. [Epub ahead of print]

PMID:
30045933
7.

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC.

Santini FC, Rizvi H, Plodkowski AJ, Ni A, Lacouture ME, Gambarin-Gelwan M, Wilkins O, Panora E, Halpenny DF, Long NM, Kris MG, Rudin CM, Chaft JE, Hellmann MD.

Cancer Immunol Res. 2018 Sep;6(9):1093-1099. doi: 10.1158/2326-6066.CIR-17-0755. Epub 2018 Jul 10.

PMID:
29991499
8.

Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors.

Martin M, Sabari JK, Turashvili G, Halpenny DF, Rizvi H, Shapnik N, Makker V.

Gynecol Oncol Rep. 2018 Apr 18;24:94-98. doi: 10.1016/j.gore.2018.04.004. eCollection 2018 May.

9.

The Undergraduate Training in Genomics (UTRIG) Initiative: early & active training for physicians in the genomic medicine era.

Wilcox RL, Adem PV, Afshinnekoo E, Atkinson JB, Burke LW, Cheung H, Dasgupta S, DeLaGarza J, Joseph L, LeGallo R, Lew M, Lockwood CM, Meiss A, Norman J, Markwood P, Rizvi H, Shane-Carson KP, Sobel ME, Suarez E, Tafe LJ, Wang J, Haspel RL.

Per Med. 2018 May 1;15(3):199-208. doi: 10.2217/pme-2017-0077. Epub 2018 May 30.

10.

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV.

Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.

PMID:
29773717
11.

Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders.

Leonardi GC, Gainor JF, Altan M, Kravets S, Dahlberg SE, Gedmintas L, Azimi R, Rizvi H, Riess JW, Hellmann MD, Awad MM.

J Clin Oncol. 2018 Jul 1;36(19):1905-1912. doi: 10.1200/JCO.2017.77.0305. Epub 2018 May 10.

PMID:
29746230
12.

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Hellmann MD, Nathanson T, Rizvi H, Creelan BC, Sanchez-Vega F, Ahuja A, Ni A, Novik JB, Mangarin LMB, Abu-Akeel M, Liu C, Sauter JL, Rekhtman N, Chang E, Callahan MK, Chaft JE, Voss MH, Tenet M, Li XM, Covello K, Renninger A, Vitazka P, Geese WJ, Borghaei H, Rudin CM, Antonia SJ, Swanton C, Hammerbacher J, Merghoub T, McGranahan N, Snyder A, Wolchok JD.

Cancer Cell. 2018 May 14;33(5):843-852.e4. doi: 10.1016/j.ccell.2018.03.018. Epub 2018 Apr 12.

13.

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer.

Derosa L, Hellmann MD, Spaziano M, Halpenny D, Fidelle M, Rizvi H, Long N, Plodkowski AJ, Arbour KC, Chaft JE, Rouche JA, Zitvogel L, Zalcman G, Albiges L, Escudier B, Routy B.

Ann Oncol. 2018 Jun 1;29(6):1437-1444. doi: 10.1093/annonc/mdy103.

PMID:
29617710
14.

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

Rizvi H, Sanchez-Vega F, La K, Chatila W, Jonsson P, Halpenny D, Plodkowski A, Long N, Sauter JL, Rekhtman N, Hollmann T, Schalper KA, Gainor JF, Shen R, Ni A, Arbour KC, Merghoub T, Wolchok J, Snyder A, Chaft JE, Kris MG, Rudin CM, Socci ND, Berger MF, Taylor BS, Zehir A, Solit DB, Arcila ME, Ladanyi M, Riely GJ, Schultz N, Hellmann MD.

J Clin Oncol. 2018 Mar 1;36(7):633-641. doi: 10.1200/JCO.2017.75.3384. Epub 2018 Jan 16.

15.

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L.

Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.

PMID:
29097494
16.

Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern.

Kaunitz GJ, Loss M, Rizvi H, Ravi S, Cuda JD, Bleich KB, Esandrio J, Sander I, Le DT, Diaz LA Jr, Brahmer JR, Drake CG, Hollmann TJ, Lacouture ME, Hellmann MD, Lipson EJ, Taube JM.

Am J Surg Pathol. 2017 Oct;41(10):1381-1389. doi: 10.1097/PAS.0000000000000900.

17.

Ulcerated nodules in the groin of an immunosuppressed patient.

Nasir S, Van De Velde V, Rizvi H, Cerio R, Nic Fhogartaigh C, Jolliffe V, Harwood C.

Clin Exp Dermatol. 2017 Jul;42(5):558-560. doi: 10.1111/ced.13095. Epub 2017 Jun 7. No abstract available.

PMID:
28589546
18.

Nivolumab induced myxedema crisis.

Khan U, Rizvi H, Sano D, Chiu J, Hadid T.

J Immunother Cancer. 2017 Feb 21;5:13. doi: 10.1186/s40425-017-0213-x. eCollection 2017.

19.

Sweet syndrome: a painful reality.

Khan U, Rizvi H, Ali F, Lebovic D.

BMJ Case Rep. 2016 Dec 23;2016. pii: bcr2016217606. doi: 10.1136/bcr-2016-217606.

PMID:
28011887
20.

Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer.

Osorio JC, Ni A, Chaft JE, Pollina R, Kasler MK, Stephens D, Rodriguez C, Cambridge L, Rizvi H, Wolchok JD, Merghoub T, Rudin CM, Fish S, Hellmann MD.

Ann Oncol. 2017 Mar 1;28(3):583-589. doi: 10.1093/annonc/mdw640.

21.

Hybrid boron nitride-natural fiber composites for enhanced thermal conductivity.

Xia C, Garcia AC, Shi SQ, Qiu Y, Warner N, Wu Y, Cai L, Rizvi HR, D'Souza NA, Nie X.

Sci Rep. 2016 Oct 5;6:34726. doi: 10.1038/srep34726.

22.

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

Naidoo J, Wang X, Woo KM, Iyriboz T, Halpenny D, Cunningham J, Chaft JE, Segal NH, Callahan MK, Lesokhin AM, Rosenberg J, Voss MH, Rudin CM, Rizvi H, Hou X, Rodriguez K, Albano M, Gordon RA, Leduc C, Rekhtman N, Harris B, Menzies AM, Guminski AD, Carlino MS, Kong BY, Wolchok JD, Postow MA, Long GV, Hellmann MD.

J Clin Oncol. 2017 Mar;35(7):709-717. doi: 10.1200/JCO.2016.68.2005. Epub 2016 Sep 30.

23.

Interrelationship of serum S100B and P53 in brain tumour patients.

Syeda T, Rizvi HA, Hadi SM, M Hashim AS, Khan MH.

J Pak Med Assoc. 2016 Jun;66(6):748-50.

24.

Cadmium stress in rice: toxic effects, tolerance mechanisms, and management: a critical review.

Rizwan M, Ali S, Adrees M, Rizvi H, Zia-Ur-Rehman M, Hannan F, Qayyum MF, Hafeez F, Ok YS.

Environ Sci Pollut Res Int. 2016 Sep;23(18):17859-79. doi: 10.1007/s11356-016-6436-4. Epub 2016 Mar 21. Review.

PMID:
26996904
25.

Property enhancement of soy protein isolate-based films by introducing POSS.

Xia C, Zhang S, Shi SQ, Cai L, Garcia AC, Rizvi HR, D'Souza NA.

Int J Biol Macromol. 2016 Jan;82:168-73. doi: 10.1016/j.ijbiomac.2015.11.024. Epub 2015 Nov 14.

PMID:
26586590
26.

Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance.

Kirwan DE, Ugarte-Gil C, Gilman RH, Caviedes L, Rizvi H, Ticona E, Chavez G, Cabrera JL, Matos ED, Evans CA, Moore DA, Friedland JS; Lymph Node TB Working Group, Peru.

J Clin Microbiol. 2016 Jan;54(1):185-9. doi: 10.1128/JCM.02227-15. Epub 2015 Oct 28.

27.

United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findings.

Rizvi H, Butler T, Calaminici M, Doobaree IU, Nandigam RC, Bennett D, Provan D, Newland AC.

Br J Haematol. 2015 May;169(4):590-4. doi: 10.1111/bjh.13330. Epub 2015 Mar 5.

PMID:
25753327
28.

Antitumor effects of hyaluronan inhibition in desmoid tumors.

Briggs A, Rosenberg L, Buie JD, Rizvi H, Bertagnolli MM, Cho NL.

Carcinogenesis. 2015 Feb;36(2):272-9. doi: 10.1093/carcin/bgu324. Epub 2015 Jan 2.

PMID:
25556151
29.

Generalized equilibrium problem with mixed relaxed monotonicity.

Rizvi HA, Kılıçman A, Ahmad R.

ScientificWorldJournal. 2014;2014:807324. doi: 10.1155/2014/807324. Epub 2014 Jul 10.

30.

Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.

Agostinelli C, Rizvi H, Paterson J, Shende V, Akarca AU, Agostini E, Fuligni F, Righi S, Spagnolo S, Piccaluga PP, Clark EA, Pileri SA, Marafioti T.

Am J Surg Pathol. 2014 Oct;38(10):1349-59. doi: 10.1097/PAS.0000000000000309.

PMID:
25118816
31.

Pre- and post-operative values of serum CRP in patients undergoing surgery for brain tumour.

Syeda T, Hashim AS, Rizvi HA, Hadi SM.

J Pak Med Assoc. 2014 Mar;64(3):271-4.

32.

Influence of Pseudomonas aeruginosa as PGPR on oxidative stress tolerance in wheat under Zn stress.

Islam F, Yasmeen T, Ali Q, Ali S, Arif MS, Hussain S, Rizvi H.

Ecotoxicol Environ Saf. 2014 Jun;104:285-93. doi: 10.1016/j.ecoenv.2014.03.008. Epub 2014 Apr 15.

PMID:
24726941
33.

Lack of anti-tumor activity with the β-catenin expression inhibitor EZN-3892 in the C57BL/6J Min/+ model of intestinal carcinogenesis.

Hasson RM, Briggs A, Rizvi H, Carothers AM, Davids JS, Bertagnolli MM, Cho NL.

Biochem Biophys Res Commun. 2014 Feb 14;444(3):283-9. doi: 10.1016/j.bbrc.2013.11.135. Epub 2014 Jan 31.

PMID:
24486542
34.

Bone Glue Modified Asphalt: A Step towards Energy Conservation and Environment Friendly Modified Asphalts.

Rizvi HR, Khattak MJ, Gallo AA.

Int Sch Res Notices. 2014 Sep 29;2014:807043. doi: 10.1155/2014/807043. eCollection 2014.

35.

Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients.

Jabeen F, Fawwad A, Rizvi HA, Alvi F.

Pak J Med Sci. 2013 Jan;29(1):152-6. doi: 10.12669/pjms.291.2592.

36.

BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia.

Akarca AU, Shende VH, Ramsay AD, Diss T, Pane-Foix M, Rizvi H, Calaminici MR, Grogan TM, Linch D, Marafioti T.

Br J Haematol. 2013 Sep;162(6):848-51. doi: 10.1111/bjh.12429. Epub 2013 Jul 13. No abstract available.

PMID:
23848818
37.

Serum S100B in patients with brain tumours undergoing craniotomy.

Syeda T, Muhammad Hashim AS, Rizvi HA, Hadi SM.

J Coll Physicians Surg Pak. 2013 Feb;23(2):112-5. doi: 02.2013/JCPSP.112115.

PMID:
23374513
38.

Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue.

Rizvi H, Paterson JC, Tedoldi S, Ramsay A, Calaminici M, Natkunam Y, Lonardi S, Tan SY, Campbell L, Hansmann ML, Jones D, Dikic I, Shaw AS, Pileri SA, Stein H, Mason DY, Facchetti F, Marafioti T.

Pathologica. 2012 Apr;104(2):56-64.

PMID:
22953501
39.

Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.

Carothers AM, Rizvi H, Hasson RM, Heit YI, Davids JS, Bertagnolli MM, Cho NL.

Cancer Res. 2012 Jan 1;72(1):346-55. doi: 10.1158/0008-5472.CAN-11-2819. Epub 2011 Nov 17.

40.

Cutaneous mucinous carcinoma arising in extramammary Paget disease of the perineum.

Matin RN, Gibbon K, Rizvi H, Harwood CA, Cerio R.

Am J Dermatopathol. 2011 Oct;33(7):705-9. doi: 10.1097/DAD.0b013e3181f9c83d.

PMID:
21885944
41.

An unusual case of vulval papulonecrotic tuberculid.

Wong S, Rizvi H, Cerio R, O'Toole EA.

Clin Exp Dermatol. 2011 Apr;36(3):277-80. doi: 10.1111/j.1365-2230.2010.03925.x. Epub 2010 Sep 30.

PMID:
21418269
42.

Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumors.

Cho NL, Carothers AM, Rizvi H, Hasson RM, Redston M, Bertagnolli MM.

J Surg Res. 2012 Apr;173(2):320-6. doi: 10.1016/j.jss.2010.10.037. Epub 2010 Nov 26.

PMID:
21195420
43.

A patient with CLL and a dry cough.

Tsitsikas DA, Vinicombe S, Sheaff M, Ellis S, Rizvi H, Manuel R, Agrawal SG.

BMJ. 2010 Jun 30;340:c3051. doi: 10.1136/bmj.c3051. No abstract available.

PMID:
20591962
44.

Awareness and prevention of osteoporosis among South Asian women.

Shakil A, Gimpel NE, Rizvi H, Siddiqui Z, Ohagi E, Billmeier TM, Foster B.

J Community Health. 2010 Aug;35(4):392-7. doi: 10.1007/s10900-010-9263-4.

PMID:
20373137
45.

Comparison of anaerobic dechlorinating enrichment cultures maintained on tetrachloroethene, trichloroethene, cis-dichloroethene and vinyl chloride.

Duhamel M, Wehr SD, Yu L, Rizvi H, Seepersad D, Dworatzek S, Cox EE, Edwards EA.

Water Res. 2002 Oct;36(17):4193-202.

PMID:
12420924
46.
47.

Tolerability profile of sodium mycophenolate (ERL080) and mycophenolate mofetil with and without cyclosporine (Neoral) in the rat.

Pally C, Tanner M, Rizvi H, Papageorgiou C, Schuurman HJ.

Toxicology. 2001 Jan 26;157(3):207-15.

PMID:
11164985
48.

Value of scintigraphy in chronic peritoneal dialysis patients.

Juergensen PH, Rizvi H, Caride VJ, Kliger AS, Finkelstein FO.

Kidney Int. 1999 Mar;55(3):1111-9.

49.

Growth of head among Bhoksa boys.

Nazar S, Rizvi H, Donge A.

Indian J Pediatr. 1978 Nov;45(370):364-9. No abstract available.

PMID:
311755

Supplemental Content

Support Center